Skip to main content

Advances in Therapy

Ausgabe 1/2022

Inhalt (54 Artikel)

Review

Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview

Dionysis D. Balatsoukas, Konstantinos T. Tsaousis, Konstadinos G. Boboridis, Anastasios G. Konstas, Fotis Topouzis

Open Access Review

A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives

Marc Evans, Ruth D. Lewis, Angharad R. Morgan, Martin B. Whyte, Wasim Hanif, Stephen C. Bain, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C. Patel, W. David Strain

Open Access Review

A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar

Walter Reinisch, Stanley Cohen, Monica Ramchandani, Majed Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel

Open Access Review

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

David L. Kendler, Felicia Cosman, Robert Kees Stad, Serge Ferrari

Open Access Review

Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review

Andrew J. Ostor, Ruta Sawant, Cynthia Z. Qi, Aozhou Wu, Orsolya Nagy, Keith A. Betts

Open Access Review

Drug Interactions Affecting Kidney Function: Beware of Health Threats from Triple Whammy

Tomasz Harężlak, Urszula Religioni, Filip M. Szymański, Dagmara Hering, Agnieszka Barańska, Agnieszka Neumann-Podczaska, Matthew Allan, Piotr Merks

Review

Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis

Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Ilaria Maggio, Raffaele Lodi, Daniele Angelini, Stefania Bartolini, Alba Ariela Brandes

Open Access Review

The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review

Michael S. Blaiss, Jonathan A. Bernstein, Adam Kessler, Jesse M. Pines, Carlos A. Camargo Jr., Paula Fulgham, Ryan Haumschild, Kristin Rupp, Timothy Tyler, Joseph Moellman

Open Access Review

Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials

Juan Jose Garcia Sanchez, Juliette Thompson, David A. Scott, Rachel Evans, Naveen Rao, Elisabeth Sörstadius, Glen James, Stephen Nolan, Eric T. Wittbrodt, Alyshah Abdul Sultan, Bergur V. Stefansson, Dan Jackson, Keith R. Abrams

Open Access Review

Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know

Lois E. Krahn, Phyllis C. Zee, Michael J. Thorpy

Original Research

Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study

Johan Dalén, Amy Puenpatom, Karin Luttropp, Axel Svedbom, Christopher M. Black

Original Research

Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program

Jian Gao, Shengtan Wang, Feifei Li, Haoya Xu, Xianli Li, Limei Yan, Liancheng Zhu

Open Access Original Research

Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study

Yoshito Komatsu, Shuichi Hironaka, Yoshinori Tanizawa, Zhihong Cai, Yongzhe Piao, Narikazu Boku

Open Access Original Research

Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy

Paolo Sciattella, Aldo P. Maggioni, Emanuela Arcangeli, Eduard Sidelnikov, Doreen A. Kahangire, Francesco S. Mennini

Open Access Original Research

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data

Rebecca C. Arend, David M. O’Malley, Susana Banerjee, Kimmie McLaurin, Richard Davidson, Gráinne H. Long

Open Access Original Research

Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease

Manami Yoshida, Ryosuke Tateishi, Shinzo Hiroi, Yoshie Hongo, Masakazu Fujiwara, Yoshitake Kitanishi, Kosuke Iwasaki, Tomomi Takeshima, Ataru Igarashi

Original Research

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

Vincent Cottin, Sonia Guéguen, Hilario Nunes, Stéphane Jouneau, Bruno Crestani, Philippe Bonniaud, Lidwine Wemeau, Dominique Israël-Biet, Martine Reynaud-Gaubert, Anne Gondouin, Jacques Cadranel, Sylvain Marchand-Adam, Marie Chevereau, Isabelle Dufaure-Garé, Serge Amselem, Annick Clément, Emmanuel Bergot, Philippe Bonniaud, Arnaud Bourdin, Jacques Cadranel, Cécile Chenivesse, Vincent Cottin, Bruno Crestani, Jean-Charles Dalphin, Claire Dromer, Emmanuel Gomez, Sandrine Hirschi, Dominique Israël-Biet, Stéphane Jouneau, Sylvain Marchand-Adam, David Montani, Hilario Nunes, Grégoire Prévot, Sébastien Quetant, Martine Reynaud-Gaubert, Dominique Valeyre, Lidwine Wemeau

Original Research

Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III)

Ling Li, Tao Yang, Yaoming Xue, Pengfei Ruan, Juan Du, Yunguang Li, Xia Zhang, Nan Cui, Wenying Yang

Original Research

May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?

Sergey Batskikh, Sergey Morozov, Elena Vinnitskaya, Evgeniya Sbikina, Zanna Borunova, Alexey Dorofeev, Yulia Sandler, Kirill Saliev, Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Vladimir Chulanov

Open Access Original Research

The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review

Erin Hillhouse, Karine Mathurin, Joëlle Bibeau, Diana Parison, Yasmine Rahal, Jean Lachaine, Catherine Beauchemin

Original Research

Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study

Junyu Xu, Yifei Zhang, Yiming Li, Xia Zhao, Weiwei Zhou, Corina Loghin, Lai San Tham, Xuewei Cui, Yimin Cui, Weiqing Wang

Open Access Original Research

Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study

David Nanchen, David Carballo, Stefan Bilz, Hans Rickli, Konstantinos C. Koskinas, François Mach, Christian Mueller, Carmela Crljenica, Mariagrazia Rossi, Nina Reichert, Isabella Sudano

Open Access Original Research

Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison

Simon Chowdhury, Stephane Oudard, Hiroji Uemura, Steven Joniau, Lindsay Dearden, Camille Capone, Suzy Van Sanden, Joris Diels, Boris A. Hadaschik

Open Access Original Research

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study

Xiaomeng Feng, Wei Guo, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken. H. Young, Ou Bai

Open Access COVID-19 Original Research

Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study

Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L. McCollam, Theodore Spiro, Russel Burge

Open Access Original Research

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Lin Cai, Linfeng Li, Hao Cheng, Yangfeng Ding, Zhenshu Biao, Shifa Zhang, Songmei Geng, Quanzhong Liu, Hong Fang, Zhiqi Song, Yan Lu, Shanshan Li, Qing Guo, Juan Tao, Li He, Jun Gu, Qinping Yang, Xiuping Han, Xinghua Gao, Danqi Deng, Shenqiu Li, Qingyu Wang, Jun Zhu, Jianzhong Zhang

Open Access Original Research

Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma

Divya Samineni, Weize Huang, Leonid Gibiansky, Hao Ding, Rong Zhang, Chunze Li, Arijit Sinha, Richa Rajwanshi, Kathryn Humphrey, Alexandra Bazeos, Ahmed Hamed Salem, Dale Miles

Open Access Original Research

A Qualitative Study to Characterize the Humanistic Burden of Kabuki Syndrome in the United States and Canada

Christina Theodore-Oklota, Deborah S. Hartman, Deborah L. Hoffman, Hans T. Björnsson

Open Access Original Research

Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis

Rimei Nishimura, Mayumi Taniguchi, Tomomi Takeshima, Kosuke Iwasaki

Open Access Original Research

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance

Nobuya Inagaki, Masaomi Nangaku, Yasushi Sakata, Kazuyo Sasaki, Kazumi Mori-Anai, Tomohisa Iwasaki, Koume Hamada

Open Access Original Research

Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

Andrew M. Blumenfeld, Kerry Knievel, Aubrey Manack Adams, Lawrence Severt, Matthew Butler, Hongxin Lai, David W. Dodick

Open Access Original Research

Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma

Peter Daley-Yates, Bhumika Aggarwal, Zrinka Lulic, Sourabh Fulmali, Alvaro A. Cruz, Dave Singh

Open Access Original Research

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease

Juliana Setyawan, Fan Mu, Miriam L. Zichlin, Emma Billmyer, Nathaniel Downes, Hongbo Yang, Nassir Azimi, Vibeke Strand, Andres Yarur

Open Access Original Research

The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

Juliana Setyawan, Emma Billmyer, Fan Mu, Andres Yarur, Miriam L. Zichlin, Hongbo Yang, Nathaniel Downes, Nassir Azimi, Vibeke Strand

Open Access Brief Report

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Nazzareno Galiè, Sean Gaine, Richard Channick, J. Gerry Coghlan, Marius M. Hoeper, Irene M. Lang, Vallerie V. McLaughlin, Cheryl Lassen, Lewis J. Rubin, Shu-Fang Hsu Schmitz, Olivier Sitbon, Victor F. Tapson, Kelly M. Chin

Open Access Letter

A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’

Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt, Antonio Ramirez de Arellano, Simona Gavata, Neige Morin, William J. Valentine, Barnaby Hunt

Zur Zeit gratis COVID-19 Correction

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.